Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Understanding the Bipartisan Senate Finance Prescription Drug Reform Package
“USC-Brookings Schaeffer Initiative experts unpack the bipartisan Senate Finance prescription drug reform package.
-
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
This study provides the first evidence to our knowledge that near-universal access to Medicare at age 65 is associated with improvements in population-level cancer mortality, and provides new evidence on the differences in the impact of health insurance by gender.
Posted in -
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
Experts lay out considerations for expanding the administration’s proposed model beyond Medicare Part B drugs.
Posted in -
Longitudinal Analysis of Dementia Diagnosis and Specialty Care Among Racially Diverse Medicare Beneficiaries
The burden of Alzheimer’s disease and other dementias is rapidly growing. Researchers found vast majority of dementia patients don’t receive specialty diagnosis and care.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Using the Drug Pricing Netflix Model to Help States Tackle the Hep C Crisis
Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.
-
Is This the Healthcare Policy Both Republicans and Democrats Can Agree On?
A mix of universal catastrophic coverage and private insurers would be cheaper than Medicare for All, Dana Goldman wrote in MarketWatch.
Categorized in -
The Use of Vendors in Medicare Part B Drug Payment
USC-Brookings Schaeffer Initiative experts provide an analysis of a voluntary vendor approach for Medicare to restrain drug spending for Part B drugs.
-
Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey
This paper examines racial/ethnic disparity in prescription drug cost-coping behaviors in a nationally representative sample of Medicare beneficiaries.
Categorized in -
Rep. Ruiz’s Arbitration Proposal for Surprise Billing (H.R. 3502) Would Lead to Much Higher Costs and Deficits
USC-Brookings Schaeffer Initiative researchers review the latest proposed legislation from Representative Ruiz on surprise medical billing.
-
We Need More Primary Care Physicians: Here’s Why and How
USC-Brookings Schaeffer Initiative researchers explain why we need more primary care physicians and how to close the gap between primary care and specialty medicine.